Replies to post #4881 on Humanigen Inc (fka HGENQ)

[panglozz]

I think your timeline leaves out the key "factoid" that an indictment had already been published naming Shkreli, on Monday 12/14 -- before the equity deal closed.

12/3- KBIO enters into Securities Purchase Agreement - S-1 due within 60 days etc.
** 12/3 KBIO offers options to Armistice Capital
** 12/14 -- Federal court docket publishes "Sealed Indictment" vs. Shkreli
12/15 - KBIO Securities Purchase Agreement amendment #1

12/16 - KBIO Purchase Agreement consummated via 350,224 exempt shares (@ $29.32 per share) issued.

12/17 - Shkreli arrested @ 6:30 AM
12/17 - KBIO halted shortly before 7 AM
12/17 - Shkreli terminated.

[cowtown jay]

Thank you, fireopal. But I think there's still an element missing, even beyond what panglozz added in response to your post. I wrote previously that I thought "...there were two Amendments to their Security Purchase Agreements, which both lowered the purchase price of their shares.

I didn't read the first Amendment. But the second Amendment did not apply to Officers and Directors of the company, so I assume that the first Amendment may not have applied to them, either."

I haven't been following this as closely as I would be following developments in SPNGQ. I guess that since I still haven't seen any charges filed directly related to KBIO, I don't consider Nasdaq's actions any more than just a regulatory sham, designed to keep money out of KBIO's coffers, and prevent the forward momentum of the company.

With that said, I still have not seen an 8K announcing the engagement of an auditor, and there is a 10Q and now a 10K that have to be completed. Why spend $20k per month on a consultant, if the filings aren't being addressed? Is there an insider interest in purchasing rights and assets in a fire sale from the bankruptcy court?